{"id":1736,"date":"2018-03-14T13:30:59","date_gmt":"2018-03-14T02:30:59","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/cannabis-exports-dried-cannabis-flower-and-oils-to-australia-for-novel-nose-to-brain-drug-delivery-research-by-preveceutical\/"},"modified":"2025-11-12T21:00:36","modified_gmt":"2025-11-12T10:00:36","slug":"cannabis-exports-dried-cannabis-flower-and-oils-to-australia-for-novel-nose-to-brain-drug-delivery-research-by-preveceutical","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/cannabis-exports-dried-cannabis-flower-and-oils-to-australia-for-novel-nose-to-brain-drug-delivery-research-by-preveceutical\/","title":{"rendered":"Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeutical"},"content":{"rendered":"<p><span lang=\"EN-US\">EDMONTON&nbsp;and&nbsp;VANCOUVER,&nbsp;March 13, 2018&nbsp;Aurora Cannabis Inc. and PreveCeutical Medical Inc. today announced the grant of three permits by the Australian Government, Department of Health, for the importation of cannabis into&nbsp;Australia&nbsp;for research purposes (the &#8220;Permits&#8221;). The Permits were granted to the Pharmacy Australia Centre of Excellence (&#8220;PACE&#8221;) at the&nbsp;University of Queensland&nbsp;(&#8220;UQ&#8221;) and allow PACE to import shipments of cannabis plant material for research purposes. Aurora, in turn, has received the required Canadian permits to export the cannabis to PACE.<\/span><\/p>\n<p><span lang=\"EN-US\">The cannabis will be shipped from&nbsp;Canada&nbsp;by Aurora and used for PreveCeutical&#8217;s soluble gel (&#8220;Sol-gel&#8221;) drug delivery research program (the &#8220;Program&#8221;), which is being conducted by PreveCeutical&#8217;s research partner UniQuest Pty Inc. and led by PreveCeutical&#8217;s Chief Research Officer, Dr.&nbsp;Harendra Parekh.&nbsp; The Program aims to develop a system that will increase the bioavailability of drugs by using a nose-to-brain delivery system.&nbsp;<\/span><\/p>\n<p><span lang=\"EN-US\">PreveCeutical intends to apply Sol-gel technology to cannabinoids to develop therapies for relief from a range of symptoms, including pain, inflammation, seizures and neurological disorders (see news release dated&nbsp;April 24, 2017).&nbsp; The Permits will enable PreveCeutical to test an array of cannabis strains for the development and commercialisation of cannabinoid-based Sol-gels. The advantages of Sol-gels over conventional liquid nasal sprays relate to longer therapeutic effects, reduced dosage requirements, and reduced irritation and other negative side effects.<\/span><\/p>\n<p><span lang=\"EN-US\">In consideration of the shipment, Aurora has received certain rights, including the option to either license, on a non-exclusive basis, the technology for&nbsp;Canada&nbsp;and&nbsp;Australia, or to opt for a royalty arrangement on product sales, as well as to purchase shares in PreveCeutical.<\/span><\/p>\n<p><span lang=\"EN-US\"><a href=\"https:\/\/www.newswire.ca\/news-releases\/cannabis-exports-dried-cannabis-flower-and-oils-to-australia-for-novel-nose-to-brain-drug-delivery-research-by-preveceutical-676649773.html\" target=\"_blank\" rel=\"noopener\" class=\"button\">For more<br \/><\/a><\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EDMONTON&nbsp;and&nbsp;VANCOUVER,&nbsp;March 13, 2018&nbsp;Aurora Cannabis Inc. and PreveCeutical Medical Inc. today announced the grant of three permits by the Australian Government, Department of Health, for the importation of cannabis into&nbsp;Australia&nbsp;for research purposes (the &#8220;Permits&#8221;). The Permits were granted to the Pharmacy Australia Centre of Excellence (&#8220;PACE&#8221;) at the&nbsp;University of Queensland&nbsp;(&#8220;UQ&#8221;) and allow PACE to import shipments [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":"","_wp_rev_ctl_limit":""},"categories":[15],"tags":[77],"class_list":["post-1736","post","type-post","status-publish","format-standard","hentry","category-cannabis-as-medicine","tag-cannabis-as-medicine"],"_links":{"self":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/1736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/comments?post=1736"}],"version-history":[{"count":0,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/1736\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/media?parent=1736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/categories?post=1736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/tags?post=1736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}